Coalinga fibre: A short, amphibole-free chrysotile. Part 3 - Lack of biopersistence

Indoor and Built Environment

Volumn 7, Issue 2, 1998, Pages 98-109

  Ilgren, E ^a   Chatfield, E ^a  

^a NONE

Author keywords

Biopersistence; Coalinga; Short fibre chrysotile

Indexed keywords

EID: 0002974881     PISSN: 1420326X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1420326X9800700204     Document Type: Article

References (33)

1. Ilgren E, Chatfield E: Coalinga fibre - a short, amphibole-free chrysotile. Part 1: Evidence for lack of fibrogenic activity. Indoor Built Environ 1997;6:264-276.
2. Ilgren E, Chatfield E: Coalinga fibre - a short, amphibole-free chrysotile. Part 2: Evidence for lack of tumourigenic activity. Indoor Built Environ, in press.
3. Stanton M, Wrench F: Mechanisms of mesothelioma induction with asbestos and fibrous glass. J. Natl Cancer Inst 1972;48:797-821.
4. Stanton M, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A: Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 1981;67:965-975.
5. Mossman B, Bignon J, Corn M, Seaton A, Gee JBL: Asbestos: Scientific developments and implications for public policy. Science 1990;24:294-301.
6. Biopersistence of Respirable Synthetic Fibres and Minerals. Proc Int Workshop, IARC, Lyon, 7-9 Sept, 1992. Environ Health Perspcct 1994;102(suppl 5).
7. Morgan A: Deposition of inhaled asbestos and man-made mineral fibres in the respiratory tract. Ann Occup Hyg 1995;39:747-758.
8. Brody A, Hill L, Adkins B, O'Connor R: Chrysotile asbestos inhalation in rats: Deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1981;123:670-682.
9. Pinkerton K, Plopper CG, Mercer RR, Roggli VL, Patra AL, Brody AR, Crapo JD: Airway branching patterns influence asbestos fibre location and the extent of tissue injury in the pulmonary parenchyma. Lab Invest 1986;55:688-695.
10. Pinkerton K, Pratt C, Brody AR, Crapo JD: Fibre localisation and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos. Am J Pathol 1984;117: 484-498.
11. McConnell EE, Wagner JC, Skidmore JW, Moore JA: A comparative study of the fibrogenic and carcinogenic effects of UICC Canadian chrysotile B asbestos and glass microfibre (JM 100); in Biological Effects of Man-Made Mineral Fibres. Report on a WHO/IARC Meeting, Copenhagen, 20-22 April 1982. Annex 1984;45:234-242.
12. King E, Stacy P, Holt D, Yates D, Pickle D: The colorimetric determination of silicon in the microanalysis of biological material and mineral dust. Analyst 1955;80:441.
13. Pinkerton K: Lung reaction to chronic inhalation of three types of chrysotile asbestos during the lifespan of the Fischer 344 rat; PhD thesis Duke University, 1982.
14. Pinkerton K, Young S, Fram E, Crapo J: Alveolar type II cell responses to chronic inhalation of chrysotile asbestos in rats. Am J Respir Cell Mol Biol 1990;3:543-552.
15. Muhle H, Pott F, Bellman B, Takenaka S, Ziem U: Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg 1987;131:755-764.
16. Wagner JC, Berry GB, Hill RJ, Munday DE, Skidmore JW: Animal experiments with MMM(V)F - effects of inhalation and intrapleural inoculation in rats; in Biological Effects of Man-Made Mineral Fibres. Report on a WHO/IARC Meeting, Copenhagen, 20-22 April 1982. Annex 1984;42:210-235.
17. Chang L, Overby L, Brody A, Crapo J: Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol 1988;131:156-170.
18. Pinkerton KE, Elliot AA, Frame SR, Warheit DB: Reversibility of fibrotic lesions in rats inhaling size-separated chrysotile asbestos fibres for 2 weeks. Ann Occup Hyg 1997;41: (suppl 1):178-183.
19. Crapo J: Trial testimony re: Asbestos Mass Litigation Trial (5 Sept 96). Kanawha county, W. Va. (Civil Action No. 95-8888), pp 1948-1949.
20. Wagner JC: The effects of the inhalation of asbestos in rats. Br J Cancer 1974;29:252-269.
21. Davis JM, Jones A: Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol 1988;69:717-737.
22. Davis J, Addison J, Bolton R, Donaldson K, Jones A: Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. Br J Exp Pathol 1986;67:113-129.
23. Bellmann B, Muhle H, Pott F, Konig H, Kloppel H, Spurny K: Persistence of man made mineral fibres (MMMF) and asbestos in rat lungs. Ann Occup Hyg 1987;31:693-709.
24. Churg A: Deposition and clearance of chrysotile asbestos. Ann Occup Hyg 1994;38:625-633.
25. Case B: Biological indicators of chrysotile exposure. Ann Occup Hyg 1994;38:503-518.
26. Pinkerton K, Barry B, O'Neil J, Raub J, Pratt P, Crapo J: Morphologic changes in the lung during the lifespan of Fischer 344 rats. Am J Anat 1982;164:155-174.
27. Pinkerton K, Young S, Fram E, Crapo J: Alveolar type II cell responses to chronic inhalation of chrysotile asbestos in rats. Am J Respir Cell Mol Biol 1990;3:543-552.
28. Davis JM, Jones A: Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol 1988;69:717-737.
29. Berman W, Crump K, Chatfield E, Davis J, Jones A: The sizes, shapes and mineralogy of asbestos structures that induce lung tumors or mesotheliomas in AF/HAN rats following inhalation. Risk Anal 1995;15:181-195.
30. Wagner JC, Berry G, Skidmore JW, Pooley FD: The comparative effects of three chrysotiles by injection and inhalation in rats; in Biological Effects of Mineral Fibres. I ARC Sci Pub 1980, pp 363-372.
31. Davis J, Beckett S, Bolton R, Collings P, Middleton A: Mass and number of fibres in the pathogenesis of asbestos related lung disease in rats. Br J Cancer 1978;37:673-688.
32. Davis JM: The effects of intermittent high asbestos exposure (peak dose levels) on the lungs of rats. Br J Exp Pathol 1980;61:272-279.
33. Davis J, Bolton R, Douglas A, Jones A, Smith T: Effects of electrostatic charge on the pathogenicity of chrysotile asbestos. Br J Indust Med 1988;45:292-299.